Comparison of childhood hepatic malignancies in a hepatitis B hyper-endemic area

Figure 1 Age distribution of childhood hepatocellular carcinomas (HCC) and hepatoblastomas (HB).

Figure 2 Cumulative survival curves for patients with liver malignancies in each intergroup stage. A: HCC (I vs III, P = 0.0011; III vs VI, P = 0.0002; log rank test); B: HB (I vs II, P = 0.0019; II vs III, P = 0.8783; III vs VI, P = 0.5365; log rank test).

Figure 3 Cumulative survival curves for eventually unresected HCC and HB (stages III and IV). HB-untreated compared poorly in survival with HB-chemotherapy only, HCC-untreated and HCC-chemotherapy only (P = 0.0015, 0.0040 and 0.0015; log rank test).